Deborah E. Shalev

3.3k total citations · 1 hit paper
74 papers, 2.7k citations indexed

About

Deborah E. Shalev is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Deborah E. Shalev has authored 74 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 20 papers in Organic Chemistry and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Deborah E. Shalev's work include Chemical Synthesis and Analysis (15 papers), Protein Structure and Dynamics (9 papers) and Alzheimer's disease research and treatments (8 papers). Deborah E. Shalev is often cited by papers focused on Chemical Synthesis and Analysis (15 papers), Protein Structure and Dynamics (9 papers) and Alzheimer's disease research and treatments (8 papers). Deborah E. Shalev collaborates with scholars based in Israel, United States and Switzerland. Deborah E. Shalev's co-authors include Ehud Gazit, I. M. Kustanovich, Raphael Mechoulam, Aviva Breuer, Zvi Vogel, Saleh Abu‐Lafi, Ester Fride, Amram Mor, Anat Frydman‐Marom and Assaf Friedler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Deborah E. Shalev

72 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB ₁ receptor

2001 586 citations Deborah E. Shalev et al. profile →

Peers

Countries citing papers authored by Deborah E. Shalev

Since Specialization

Citations

This map shows the geographic impact of Deborah E. Shalev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah E. Shalev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah E. Shalev more than expected).

Fields of papers citing papers by Deborah E. Shalev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah E. Shalev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah E. Shalev. The network helps show where Deborah E. Shalev may publish in the future.

Co-authorship network of co-authors of Deborah E. Shalev

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah E. Shalev. A scholar is included among the top collaborators of Deborah E. Shalev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah E. Shalev. Deborah E. Shalev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Starch–Lipid Hybrid Film as an Edible Moisture Barrier for Enhancing the Stability of Encapsulated Probiotic Bacteria 2025 ·Polymers for Advanced Technologies ·Adel Penhasi, (unknown), Deborah E. Shalev	0
2	Self-Assembly of a Dipeptide with a Reduced Amount of Copper into Antifungal and Antibacterial Particles 2024 ·Biomacromolecules ·(unknown), Muhammad Taha, (unknown), Edit Y. Tshuva, Deborah E. Shalev, Abraham Gamliel, Meital Reches	3
3	EspH utilizes phosphoinositide and Rab binding domains to interact with plasma membrane infection sites and Rab GTPases* 2024 ·Gut Microbes ·(unknown), (unknown), Deborah E. Shalev, Dina Schneidman‐Duhovny, (unknown), Naomi Melamed‐Book, (unknown), Alexander Rouvinski, Ilan Rosenshine, Benjamin Aroeti	1
4	Structural insights into the role of the WW2 domain on tandem WW–PPxY motif interactions of oxidoreductase WWOX 2022 ·Journal of Biological Chemistry ·Shahar Rotem‐Bamberger, (unknown), Keren Keinan‐Adamsky, Tomer Tsaban, Orly Avraham, Deborah E. Shalev, Jordan H. Chill, Ora Schueler‐Furman	4
5	Diselenide crosslinks for enhanced and simplified oxidative protein folding 2021 ·Communications Chemistry ·Reem Mousa, (unknown), (unknown), Shifra Lansky, (unknown), Deborah E. Shalev, G. Shoham, Norman Metanis	26
6	Mass spectrometry reveals the chemistry of formaldehyde cross-linking in structured proteins 2020 ·Nature Communications ·(unknown), Moriya Slavin, (unknown), (unknown), (unknown), (unknown), Xue Sun, Deborah E. Shalev, Oren Ram, Nir Kalisman	84
7	Cyclizing Painkillers: Development of Backbone-Cyclic TAPS Analogs 2020 ·Frontiers in Chemistry ·(unknown), (unknown), (unknown), Oded Ovadia, (unknown), (unknown), David Rosenthal, Deborah E. Shalev, Mattan Hurevich, Philip Lazarovici, Amnon Hoffman, Chaim Gilon	5
8	Unbound position II in MXCXXC metallochaperone model peptides impacts metal binding mode and reactivity: Distinct similarities to whole proteins 2016 ·Journal of Inorganic Biochemistry ·(unknown), (unknown), (unknown), Deborah E. Shalev, Tsafi Danieli, Mario Lebendiker, Wojciech Bal, Edit Y. Tshuva	13
9	Backbone cyclic helix mimetic of chemokine (C–C motif) receptor 2: A rational approach for inhibiting dimerization of G protein-coupled receptors 2013 ·Bioorganic & Medicinal Chemistry ·Mattan Hurevich, (unknown), Yftah Tal‐Gan, Deborah E. Shalev, Shlomo Z. Ben‐Sasson, Chaim Gilon	8
10	Mechanism of the Interaction between the Intrinsically Disordered C-Terminus of the Pro-Apoptotic ARTS Protein and the Bir3 Domain of XIAP 2011 ·PLoS ONE ·(unknown), Deborah E. Shalev, Shahar Sukenik, (unknown), Shahar Rotem‐Bamberger, Mario Lebendiker, Sarit Larisch, Assaf Friedler	17
11	Osmolytes Induce Changes in the Conformational Landscape of a Model Peptide 2011 ·Biophysical Journal ·Liel Sapir, Deborah E. Shalev, Daniel Harries	1
12	NMR characterization of a Cu(i)-bound peptide model of copper metallochaperones: Insights on the role of methionine 2011 ·Chemical Communications ·(unknown), Deborah E. Shalev, Wencke Adriaens, Matthias A.W. Merkx, Tilman M. Hackeng, Edit Y. Tshuva	8
13	Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies 2010 ·PLoS ONE ·Ronit Shaltiel‐Karyo, Moran Frenkel‐Pinter, (unknown), Anat Frydman‐Marom, Deborah E. Shalev, Daniel Segal, Ehud Gazit	98
14	Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor 2010 ·PLoS ONE ·Roni Scherzer‐Attali, Riccardo Pellarin, Marino Convertino, Anat Frydman‐Marom, (unknown), (unknown), Michal Levy‐Sakin, Deborah E. Shalev, Amedeo Caflisch, Ehud Gazit, Daniel Segal	126
15	The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state 2009 ·Protein Engineering Design and Selection ·(unknown), Hadar Benyamini, Mario Lebendiker, Deborah E. Shalev, Assaf Friedler	23
16	Development of bifunctional photoactivatable benzophenone probes and their application to glycoside substrates 2008 ·Biopolymers ·Nir Qvit, (unknown), (unknown), Deborah E. Shalev, Orna Amster‐Choder, Chaim Gilon	13
17	Cognitive‐Performance Recovery of Alzheimer's Disease Model Mice by Modulation of Early Soluble Amyloidal Assemblies 2008 ·Angewandte Chemie International Edition ·Anat Frydman‐Marom, Meirav Rechter, Irit Shefler, Yaron Bram, Deborah E. Shalev, Ehud Gazit	124
18	Design and synthesis of backbone cyclic phosphorylated peptides: The IκB model 2008 ·Biopolymers ·Nir Qvit, Ada Hatzubai, Deborah E. Shalev, Assaf Friedler, Yinon Ben‐Neriah, Chaim Gilon	14
19	Using peptides to study the interaction between the p53 tetramerization domain and HIV‐1 tat 2008 ·Biopolymers ·Ronen Gabizon, (unknown), Masha M. Rosenberg, (unknown), Zvi Hayouka, Moshe Kotler, Deborah E. Shalev, Assaf Friedler	21
20	Positively charged peptides can interact with each other, as revealed by solid phase binding assays 2006 ·Analytical Biochemistry ·Joseph Rosenbluh, (unknown), Deborah E. Shalev, Marco Rusnati, Antonella Bugatti, Abraham Loyter	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact